These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1662896)

  • 21. Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():39-44. PubMed ID: 1664828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR; Braeckman R; Kraut J; Shupien S; Craft JC
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2345-51. PubMed ID: 1666497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of temafloxacin in humans after single oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits.
    Elmas M; Yazar E; Baş AL; Traş B; Bayezit M; Yapar K
    J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):507-12. PubMed ID: 12485362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of sparfloxacin.
    Shimada J; Nogita T; Ishibashi Y
    Clin Pharmacokinet; 1993 Nov; 25(5):358-69. PubMed ID: 8287631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR
    Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of temafloxacin on the pharmacokinetics of theophylline.
    Ruff F; Santais MC; Callens E; Chauvin JP; Hazebroucq J
    Am J Med; 1991 Dec; 91(6A):76S-80S. PubMed ID: 1662899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.
    Intorre L; Mengozzi G; Bertini S; Bagliacca M; Luchetti E; Soldani G
    Vet Res Commun; 1997 Feb; 21(2):127-36. PubMed ID: 9061885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
    Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
    Zabinski RA; Vance-Bryan K; Krinke AJ; Walker KJ; Moody JA; Rotschafer JC
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2454-8. PubMed ID: 8285633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
    Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE; Philip E
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.